8-Bromo-7-(2-butyn-1-yl) -3-methylxanthine CAS 666816-98-4 Linagliptin Intermediate Purity ≥99.0% (HPLC) Gambar Unggul Pabrik

8-Bromo-7-(2-butyn-1-yl) -3-methylxanthine CAS 666816-98-4 Linagliptin Intermediate Purity ≥99.0% (HPLC) Pabrik

Katerangan pondok:

Ngaran: 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine

CAS: 666816-98-4

Purity: ≥99.0% (HPLC)

Penampilan: Bodas mun Pareum-Bodas Bubuk

Panengah pikeun Linagliptin (CAS: 668270-12-0) pikeun pengobatan déwasa kalayan diabetes mellitus jinis 2.

Kualitas luhur, Produksi komérsial

E-Mail: alvin@ruifuchem.com

Kirim surélék ka kami

Rincian produk

Produk patali

Tag produk

Katerangan:

Produsén Pasokan Linagliptin sareng Panganteur Patali:
Linagliptin CAS 668270-12-0
Linagliptin Induk inti CAS panengah 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Klorométil)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidin CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0

Sipat Kimia:

Ngaran Kimia	8-Bromo-7-(2-butyn-1-il)-3-methylxanthine
sinonim	8-Bromo-7-(2-butyn-1-yl) -3,7-dihydro-3-methyl-1H-purine-2,6-dione;Linagliptin Intermediate C
Nomer CAS	666816-98-4
Nomer CAT	RF-PI497
Status saham	Dina Stok, Skala Produksi Nepi ka Ton
Formula Molekul	C10H9BrN4O2
Beurat Molekul	297.11
Titik Lebur	285 ℃
merek	Kimia Ruifu

spésifikasi:

Barang	spésifikasi
Penampilan	Bodas ka Pareum-Bodas Bubuk
Cai (KF)	≤0,50%
Résidu on Ignition	≤0,50%
Purity / Métode Analisis	≥99,0% (HPLC)
Max Single Impurity	≤0,50%
Sésa pangleyur
Étanol	≤5000ppm
DMF	≤3000ppm
Standar tés	Standar Perusahaan
Pamakéan	Panengah pikeun Linagliptin (CAS: 668270-12-0)

Paket & Panyimpenan:

Bungkusan: Botol, kantong Aluminium foil, 25kg / Karton Drum, atawa nurutkeun sarat customer urang.

Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap.

Kaunggulan:

FAQ:

Aplikasi:

8-Bromo-7-(2-butyn-1-yl) -3-methylxanthine (CAS: 666816-98-4) mangrupa perantara pikeun Linagliptin (CAS: 668270-12-0).Linagliptin mangrupikeun sambetan oral, selektif pisan tina dipeptidyl peptidase-4 sareng mangrupikeun agén munggaran tina kelasna anu dileungitkeun sacara umum ngalangkungan jalur nonrenal.Linagliptin dituduhkeun pikeun dianggo sakali sadinten pikeun pengobatan déwasa kalayan diabetes mellitus jinis 2.Linagliptin disatujuan ku FDA AS dina Méi 2011 pikeun pengobatan diabetes Tipe 2 sareng diet sareng latihan.